CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals

Cerebrospinal fluid (CSF) YKL40 and sTREM2 are astroglial and microglial activity biomarkers, respectively. We assessed whether CSF YKL40 and sTREM2 baseline levels are associated with longitudinal brain volume and diffusivity changes in cognitively unimpaired adults. Two brain MRI scans of 36 parti...

Descripción completa

Detalles Bibliográficos
Autores: Falcón, Carles, Monté-Rubio, Gemma C., Grau, Oriol (Grau Rivera), Suárez-Calvet, Marc, Sánchez Valle, Raquel, Rami, Lorena, Bosch, Beatriz, Haass, Christian, Gispert, Juan Domingo, Molinuevo, José Luis
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/45110
Acceso en línea:http://hdl.handle.net/10230/45110
http://dx.doi.org/10.1016/j.nicl.2019.101801
Access Level:acceso abierto
Palabra clave:Longitudinal analysis
Mean diffusivity
Preclinical Alzheimer&apos
s disease
TREM2
YKL40
id ES_5c4ec85610835fe65a2fadc65ccedddd
oai_identifier_str oai:repositori.upf.edu:10230/45110
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
title CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
spellingShingle CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
Falcón, Carles
Longitudinal analysis
Mean diffusivity
Preclinical Alzheimer&apos
s disease
TREM2
YKL40
title_short CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
title_full CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
title_fullStr CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
title_full_unstemmed CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
title_sort CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals
dc.creator.none.fl_str_mv Falcón, Carles
Monté-Rubio, Gemma C.
Grau, Oriol (Grau Rivera)
Suárez-Calvet, Marc
Sánchez Valle, Raquel
Rami, Lorena
Bosch, Beatriz
Haass, Christian
Gispert, Juan Domingo
Molinuevo, José Luis
author Falcón, Carles
author_facet Falcón, Carles
Monté-Rubio, Gemma C.
Grau, Oriol (Grau Rivera)
Suárez-Calvet, Marc
Sánchez Valle, Raquel
Rami, Lorena
Bosch, Beatriz
Haass, Christian
Gispert, Juan Domingo
Molinuevo, José Luis
author_role author
author2 Monté-Rubio, Gemma C.
Grau, Oriol (Grau Rivera)
Suárez-Calvet, Marc
Sánchez Valle, Raquel
Rami, Lorena
Bosch, Beatriz
Haass, Christian
Gispert, Juan Domingo
Molinuevo, José Luis
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Longitudinal analysis
Mean diffusivity
Preclinical Alzheimer&apos
s disease
TREM2
YKL40
topic Longitudinal analysis
Mean diffusivity
Preclinical Alzheimer&apos
s disease
TREM2
YKL40
description Cerebrospinal fluid (CSF) YKL40 and sTREM2 are astroglial and microglial activity biomarkers, respectively. We assessed whether CSF YKL40 and sTREM2 baseline levels are associated with longitudinal brain volume and diffusivity changes in cognitively unimpaired adults. Two brain MRI scans of 36 participants (57 to 78-years old, 12 male) were acquired in a 2-year interval. Aβ42, p-tau, YKL40 and sTREM2 concentrations in CSF were determined at baseline. We calculated gray and white matter volume changes per year maps (ΔGM and ΔWM, respectively) by means of longitudinal pairwise registration, and mean diffusivity variation per year (ΔMD) by subtraction. We checked voxel-wise for associations between ΔGM, ΔWM and ΔMD and baseline CSF level of YKL40 and sTREM2 and verified to what extent these associations were modulated by age (YKL40xAGE and sTREM2xAGE interactions). We found a positive association between ΔGM and YKL40 in the left inferior parietal region and no association between sTREM2 and ΔGM. Negative associations were also observed between ΔGM and YKL40xAGE (bilateral frontal areas, left precuneus and left postcentral and supramarginal gyri) and sTREM2xAGE (bilateral temporal and frontal cortex, putamen and left middle cingulate gyrus). We found negative associations between ΔWM and YKL40xAGE (bilateral superior longitudinal fasciculus) and sTREM2xAGE (bilateral superior longitudinal fasciculus, left superior corona radiata, retrolenticular external capsule and forceps minor, among other regions) but none between ΔWM and neither YKL40 nor sTREM2. ΔMD was positively correlated with YKL40 in right orbital region and negatively with sTREM2 in left lingual gyrus and precuneus. In addition, significant associations were found between ΔMD and YKL40xAGE (tail of left hippocampus and surrounding areas and right anterior cingulate gyrus) and sTREM2xAGE (right superior temporal gyrus). Areas showing statistically significant differences were disjoint in analyses involving YKL40 and sTREM2. These results suggest that glial biomarkers exert a relevant and distinct influence in longitudinal brain macro- and microstructural changes in cognitively unimpaired adults, which appears to be modulated by age. In younger subjects increased glial markers (both YKL40 and sTREM2) predict a better outcome, as indicated by a decrease in ΔGM and ΔWM and an increase in ΔMD, whereas in older subjects this association is inverted and higher levels of glial markers are associated with a poorer neuroimaging outcome.
publishDate 2019
dc.date.none.fl_str_mv 2019
2020
2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/45110
http://dx.doi.org/10.1016/j.nicl.2019.101801
url http://hdl.handle.net/10230/45110
http://dx.doi.org/10.1016/j.nicl.2019.101801
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Neuroimage Clin. 2019; 23:101801
info:eu-repo/grantAgreement/EC/FP7/115568
info:eu-repo/grantAgreement/EC/H2020/752310
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/BY-NC-ND/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/BY-NC-ND/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408892656549888
spelling CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individualsFalcón, CarlesMonté-Rubio, Gemma C.Grau, Oriol (Grau Rivera)Suárez-Calvet, MarcSánchez Valle, RaquelRami, LorenaBosch, BeatrizHaass, ChristianGispert, Juan DomingoMolinuevo, José LuisLongitudinal analysisMean diffusivityPreclinical Alzheimer&aposs diseaseTREM2YKL40Cerebrospinal fluid (CSF) YKL40 and sTREM2 are astroglial and microglial activity biomarkers, respectively. We assessed whether CSF YKL40 and sTREM2 baseline levels are associated with longitudinal brain volume and diffusivity changes in cognitively unimpaired adults. Two brain MRI scans of 36 participants (57 to 78-years old, 12 male) were acquired in a 2-year interval. Aβ42, p-tau, YKL40 and sTREM2 concentrations in CSF were determined at baseline. We calculated gray and white matter volume changes per year maps (ΔGM and ΔWM, respectively) by means of longitudinal pairwise registration, and mean diffusivity variation per year (ΔMD) by subtraction. We checked voxel-wise for associations between ΔGM, ΔWM and ΔMD and baseline CSF level of YKL40 and sTREM2 and verified to what extent these associations were modulated by age (YKL40xAGE and sTREM2xAGE interactions). We found a positive association between ΔGM and YKL40 in the left inferior parietal region and no association between sTREM2 and ΔGM. Negative associations were also observed between ΔGM and YKL40xAGE (bilateral frontal areas, left precuneus and left postcentral and supramarginal gyri) and sTREM2xAGE (bilateral temporal and frontal cortex, putamen and left middle cingulate gyrus). We found negative associations between ΔWM and YKL40xAGE (bilateral superior longitudinal fasciculus) and sTREM2xAGE (bilateral superior longitudinal fasciculus, left superior corona radiata, retrolenticular external capsule and forceps minor, among other regions) but none between ΔWM and neither YKL40 nor sTREM2. ΔMD was positively correlated with YKL40 in right orbital region and negatively with sTREM2 in left lingual gyrus and precuneus. In addition, significant associations were found between ΔMD and YKL40xAGE (tail of left hippocampus and surrounding areas and right anterior cingulate gyrus) and sTREM2xAGE (right superior temporal gyrus). Areas showing statistically significant differences were disjoint in analyses involving YKL40 and sTREM2. These results suggest that glial biomarkers exert a relevant and distinct influence in longitudinal brain macro- and microstructural changes in cognitively unimpaired adults, which appears to be modulated by age. In younger subjects increased glial markers (both YKL40 and sTREM2) predict a better outcome, as indicated by a decrease in ΔGM and ΔWM and an increase in ΔMD, whereas in older subjects this association is inverted and higher levels of glial markers are associated with a poorer neuroimaging outcome.The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115568, resources of which are composed of financial contribution from the European Union‘s Seventh Framework Programme (FP7/2007–2013) and EFPIA companies’ in-kind contribution. Juan D Gispert holds a ‘Ramón y Cajal’ fellowship (RYC-2013-13054) and Lorena Rami is part of the ‘Programa de Investigadores del Sistema Nacional Miguel Servet II’ (CPII14/00023; IP: Lorena Rami). Marc Suárez-Calvet was awarded with an AFTD Biomarkers Initiative awards from the The Association for Frontotemporal Degeneration and receives funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie action grant agreement No 752310. This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy), Cure Alzheimer's Fund and MetLife Foundation Award (to Christian Haass). The present communication reflects the authors' view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.Elsevier202020202019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/45110http://dx.doi.org/10.1016/j.nicl.2019.101801reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésNeuroimage Clin. 2019; 23:101801info:eu-repo/grantAgreement/EC/FP7/115568info:eu-repo/grantAgreement/EC/H2020/752310© 2019 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).http://creativecommons.org/licenses/BY-NC-ND/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/451102026-06-12T07:21:37Z
score 15,81155